Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on UNITED NATURAL FOODS INC. We currently have 0 research reports from 0 professional analysts.
Frequency of research reports
Research reports on
UNITED NATURAL FOODS INC
UNITED NATURAL FOODS INC
17 Jan 17
Greggs' trading update confirmed that it delivered a stronger than expected finish to FY16, leaving it well placed to face the margin pressures that will affect the entire industry in FY17. We expect only modest changes to FY17 estimates when FY16 results are released and therefore continue to value the shares at 1,189p.
In line with expectations
12 Oct 16
Greggs enjoys a differentiated position in the growing food-to-go market. Its strategy to enhance its offer and improve the efficiency with which it delivers that offer has yielded good results so far and remains on track. Although the industry faces input cost headwinds in FY17, Greggs has the financial strength to withstand them and the benefit of the continuing strategic initiatives to offset them.
More in the oven
26 Feb 16
The investment case remains quite compelling given further internally driven top-line and margin enhancement potential. Greggs is now entering year 3 of a 5 year ransformation programme, so there is still a lot more to do. Whilst an FY16 P/E of 18x looks up with events, we feel there is good momentum for upgrades to flow through as 2016 progresses and for the shares to outperform.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.